• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evaluation of inhibitory drug interactions during drug development: genetic polymorphisms must be considered.

作者信息

Lee Lois S, Nafziger Anne N, Bertino Joseph S

机构信息

Clinical Pharmacology Research Center, The Research Institute, Bassett Healthcare, USA.

出版信息

Clin Pharmacol Ther. 2005 Jul;78(1):1-6. doi: 10.1016/j.clpt.2005.04.006.

DOI:10.1016/j.clpt.2005.04.006
PMID:16003286
Abstract
摘要

相似文献

1
Evaluation of inhibitory drug interactions during drug development: genetic polymorphisms must be considered.药物研发过程中抑制性药物相互作用的评估：必须考虑基因多态性。
Clin Pharmacol Ther. 2005 Jul;78(1):1-6. doi: 10.1016/j.clpt.2005.04.006.
2
[Genetic polymorphism of drug metabolizing enzymes].[药物代谢酶的基因多态性]
Seikagaku. 1997 Oct;69(10):1196-9.
3
The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ultrarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 or CYP2C19.治疗窗在理解服用由CYP2D6或CYP2C19代谢药物的受试者中慢代谢型与超快代谢型表型的临床相关性方面的关键作用。
J Clin Psychopharmacol. 2007 Jun;27(3):241-5. doi: 10.1097/JCP.0b013e318058244d.
4
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.意大利人群中CYP2C9、CYP2C19和CYP2D6的等位基因及基因型频率
Pharmacol Res. 2004 Aug;50(2):195-200. doi: 10.1016/j.phrs.2004.01.004.
5
[Genetic polymorphism of CYP-450 in drug development].[药物研发中细胞色素P450的基因多态性]
Nihon Yakurigaku Zasshi. 2009 Oct;134(4):212-5. doi: 10.1254/fpj.134.212.
6
[Genotyping of CYP2D6 and CYP2C19].[细胞色素P450 2D6和细胞色素P450 2C19基因分型]
Cas Lek Cesk. 2007;146(9):708-11.
7
Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus-associated hepatocellular carcinoma.丙型肝炎病毒相关肝细胞癌患者细胞色素P450的基因多态性
J Gastroenterol Hepatol. 2005 Aug;20(8):1191-7. doi: 10.1111/j.1440-1746.2005.03808.x.
8
[Status of pharmacogenomics and its future role in drug therapy].[药物基因组学的现状及其在药物治疗中的未来作用]
Internist (Berl). 2002 Apr;43(4):506-10. doi: 10.1007/s00108-002-0558-0.
9
Adverse drug reaction monitoring in Jena. Relevance of polymorphic drug metabolizing enzymes for inducing adverse drug reactions.耶拿的药物不良反应监测。多态性药物代谢酶在引发药物不良反应中的相关性。
Exp Toxicol Pathol. 2003 Jun;54(5-6):417-21. doi: 10.1078/0940-2993-00278.
10
Phenotyping of drug metabolism in infants and children: potentials and problems.
Pediatrics. 1999 Sep;104(3 Pt 2):640-3.

引用本文的文献

1
Taste and Smell Disorders in Cancer Treatment: Results from an Integrative Rapid Systematic Review.癌症治疗中的味觉和嗅觉障碍：综合快速系统评价的结果。
Int J Mol Sci. 2023 Jan 28;24(3):2538. doi: 10.3390/ijms24032538.
2
Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives.涉及细胞色素 P450 的复杂药物-药物-基因-疾病相互作用：已发表病例报告的系统评价和临床观点。
Clin Pharmacokinet. 2018 Oct;57(10):1267-1293. doi: 10.1007/s40262-018-0650-9.
3
Effects of the Chinese herbal formula "Zuojin Pill" on the pharmacokinetics of dextromethorphan in healthy Chinese volunteers with CYP2D6*10 genotype.
中药方剂“左金丸”对CYP2D6*10基因型健康中国志愿者体内右美沙芬药代动力学的影响。
Eur J Clin Pharmacol. 2016 Jun;72(6):689-95. doi: 10.1007/s00228-016-2048-7. Epub 2016 Mar 29.
4
Pharmacokinetic drug interactions in liver disease: An update.肝病中的药代动力学药物相互作用：最新进展。
World J Gastroenterol. 2016 Jan 21;22(3):1260-78. doi: 10.3748/wjg.v22.i3.1260.
5
Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype dependent.依非韦伦介导的奥美拉唑代谢诱导作用取决于CYP2C19基因分型。
Pharmacogenomics J. 2014 Apr;14(2):151-9. doi: 10.1038/tpj.2013.17. Epub 2013 Apr 30.
6
Impact of the CYP2C8 *3 polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone.CYP2C8*3 多态性对吉非贝齐与吡格列酮药物相互作用的影响。
Br J Clin Pharmacol. 2013 Jan;75(1):217-26. doi: 10.1111/j.1365-2125.2012.04343.x.
7
Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism.生物转化在药物诱导毒性中的作用：药物代谢的种内和种间差异的影响。
Drug Metab Pharmacokinet. 2011;26(1):15-29. doi: 10.2133/dmpk.dmpk-10-rv-089. Epub 2010 Oct 22.
8
Pharmacogenomics: challenges and opportunities.药物基因组学：挑战与机遇。
Ann Intern Med. 2006 Nov 21;145(10):749-57. doi: 10.7326/0003-4819-145-10-200611210-00007.
9
Impact of CYP2D6*10 on H1-antihistamine-induced hypersomnia.细胞色素P450 2D6*10对H1抗组胺药引起的嗜睡的影响。
Eur J Clin Pharmacol. 2006 Dec;62(12):995-1001. doi: 10.1007/s00228-006-0210-3. Epub 2006 Nov 7.
10
Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources.全科医疗中质子泵抑制剂的相互作用风险：不同药物相关信息来源之间存在显著分歧。
Br J Clin Pharmacol. 2006 Nov;62(5):582-90. doi: 10.1111/j.1365-2125.2006.02687.x. Epub 2006 Jul 6.